[1] [1] J. N. Cormier, R. L. Askew, K. S. Mungovan, Y. Xing, M. I. Ross, J. M. Armer, “Lymphedema beyond breast cancer: A systematic review and meta-analysis of cancer-related secondary lymphedema,” Cancer 116, 5138–5149 (2010).

[2] [2] M. Foldi, E. Foldi, Foldi’s Textbook of Lymphology, 2nd Edition, Elsevier GmbH, (2006).

[3] [3] P. Klernas, L. J. Kristjanson, K. Johansson, “Assessment of quality of life in lymphedema patients: Validity and reliability of the Swedish version of the Lymphedema Quality of Life Inventory (LQOLI),” Lymphology 43, 135–145 (2010).

[4] [4] M. R. Fu, “Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management,” World J. Clin. Oncol. 5, 241–247 (2014).

[5] [5] D. M. Smeltzer, G. B. Stickler, A. Shirger, “Primary lymphedema in children and adolescents: A follow-up study and review,” Pediatrics 76, 206–218 (1985).

[6] [6] http://rarediseases.org/rare-diseases/hereditary-lymphedema/.

[7] [7] R. T. Eberhart, J. D. Raffetto, “Chronic venous insufficiency,” Circulation 130, 333–346 (2014).

[8] [8] N. L. Stout Gergich, L. A. Pfalzer, C. McGarvey, B. Springer, L. H. Gerber, P. Soballe, “Preoperative assessment enables the early diagnosis and successful treatment of lymphedema,” Cancer 112, 2809–2819 (2008).

[9] [9] C. Ketterer, “Surgical options for lymphedema following breast cancer treatment,” Plast. Surg. Nurses J. 34, 82–85 (2014).

[10] [10] D. W. Chang, H. Suami, R. Skoracki, “A prospective analysis of 100 consecutive lymhovenous bypass cases for treatment of extremity lymphedema, Plast. Reconstr. Surg. 132, 1305–1314 (2013).

[11] [11] R. J. Allen Jr., M-H. Cheng, “Lymphedema surgery: Patient selection and an overview of surgical techniques,” J. Surg. Oncol. 113, 923–931 (2016).

[12] [12] C. Becker, J. Assouad, M. Riquet, G. Hidden, “Post-mastectomy lymphedema: Long-term results following microsurgical lymph node transplantation,” Ann. Surg. 243, 313–315 (2006).

[13] [13] M. Mihara, H. Hara, S. Tange, H. P. Zhou, M. Kawahara, Y. Shimizu, N. Murai, “Multisite lymphaticovenular bypass using supermicrosurgery technique for lymphedema management in lower lymphedema cases,” Plast. Reconstr. Surg. 138, 262–272 (2016).

[14] [14] M. F. Scaglioni, M. Arvanitakis, Y. C. Chen, P. Giovanoli, C-S. Yang, E. I. Chang, “Comprehensive review of vascularized lymph node transfers for lymphedema: Outcomes and complications,” Microsurgery, Jun 07, doi: 10.1002/micr.30079 (2016) [Epub ahead of print].

[15] [15] The diagnosis and treatment of pheripheral lymphedema: 2013 consensus document of the International Society of Lymphology, Lymphology 46, 1–11 (2013).

[16] [16] I-C. Tan, E. A. Maus, J. C. Rasmussen, M. V. Marshall, K. E. Adams, C. E. Fife, L. A. Smith, W. Chan, E. M. Sevick-Muraca, “Assessment of lymphatic contractile function after manual lymphatic drainage using near-infrared fluorescence imaging,” Arch. Phys. Med. Rehabil. 92, 756–764 (2011).

[17] [17] K. Ashforth, E. A. Maus, F. J. Schingale, A protocol for pneumatic compression home use, Abstract, World Congress of Lymphology, San Francisco USA, Sept. (2015).

[18] [18] Mego Afek Ac Ltd., Israel www.lympha-press.com.

[19] [19] C. J. Pappas, T. F. O’Donnell Jr., “ Long-term results of compression treatment for lymphedema,” J. Vasc. Surg. 16, 555–564 (1992).

[20] [20] D. M. Richmand, T. F. O’Donnell Jr, A. Zelikovski, “Sequential pneumatic compression for lymphedema—a controlled trial,” Arch. Surg. 120, 1116–1119 (1985).

[21] [21] K. Johannsson, E. Lie, C. Ekdahl, J. Lindfeldt, “A randomized study comparing manual lymph drainage with sequential pneumatic compression for treatment of postoperative arm lymphedema,” Lymphology 31, 56–64 (1998).

[22] [22] O. Wilburn, P. Wilburn, S. G. Rockson, “A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412],” BMC Cancer 6, 84 (2006).

[23] [23] P. Karaca-Mandic, A. T. Hirsch, S. G. Rockson, S. H. Ridner, “The cutaneous, net clinical, and health economic benefits of advanced pneumatic compression devices in patients with lymphedema,” JAMA Dermatol. 151, 1187–1193 (2015).

[24] [24] M. Oremus, K. Walker, I. Dayes, P. Raina, Diagnosis and treatment of secondary lymphedema Technology Asessment Report 2010, USA Department of Health & Human Services Agency for Healthcare Research and Quality, May 28, (2010).

[25] [25] N. J. Preston, K. Seers, P. S. Mortimer, “Physical therapies for reducing and controlling lymphedema of the limbs,” Cochrane Database Syst Rev. Oct 18;(4):CD003141, (2004).

[26] [26] F. Baulieu, J. I., Baulieu, L. Vaillant, V. Secchi, J. Barsotti, “Factorial analysis in radionuclide lymphography: Assessment of the effects of sequential pneumatic compression,” Lymphology 22, 178–185 (1989).

[27] [27] M. V. Marshall, J. C. Rasmussen, I-C. Tan, M. B. Aldrich, K. E. Adams, X. Wang, C. E. Fife, E. A. Maus, L. A. Smith, E. M. Sevick-Muraca, “Near-infrared fluorescence imaging in humans with indocyanine green: A review and update,” Open Surg. Oncol. J. 2, 12–25 (2010).

[28] [28] T. Yamamoto, N. Matsuda, K. Doi, A. Oshima, H. Yoshimatsu, T. Todokoro, F. Ogata, M. Mihara, M. Narushima, T. Iida, I. Koshima, “The earliest finding of indocyanine green lymhography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: The modified dermal backflow stage and concept of subclinical lymphedema,” Plast. Reconstr. Surg. 128, 314e–321e (2011).

[29] [29] E. M. Sevick-Muraca, “Translation of near-infrared fluorescence imaging technologies: Emerging clinical applications,” Annu. Rev. Med. 63, 217–231 (2012).

[30] [30] F. Meric-Bernstam, J. C. Rasmussen, S. Krishnamurthy, I-C. Tan, B. Zhu, J. L. Wagner, G. V. Babiera, E. A. Mittendorf, E. M. Sevick-Muraca, “Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents,” Biomed. Opt. Exp. 5, 183–196 (2013).

[31] [31] E. M. Sevick-Muraca, S. Kwon, J. C. Rasmussen, “Emerging lymphatic imaging technologies for mouse and man,” J. Clin. Invest. 124, 905–914 (2014).

[32] [32] E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, D. K. Blanchard, R. E. Fisher, S. B. Chiang, R. Elledge, M. E. Mawad, “Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: Feasibility study,” Radiology 246, 734–741 (2008).

[33] [33] P. S. Mortimer, S. G. Rockson, “New developments in the clinical aspects of lymphatic disease,” J. Clin. Invest. 124, 915–921 (2014).

[34] [34] J. C. Rasmussen, I-C. Tan, M. V. Marshall, K. E. Adams, C. E. Fife, E. A. Maus, L. A. Smith, K. R. Covington, E. M. Sevick-Muraca, “Human lymphatic architecture and dynamic transport imaged using near-infrared fluorescence,” Transl. Oncol. 3, 362–372 (2010).

[35] [35] M. B. Aldrich, E. M. Sevick-Muraca, “Cytokines are systemic effectors of lymphatic function in acute inflammation,” Cytokine 64, 362–369 (2013).

[36] [36] X. Geng, B. Cha, M. R. Mahamud, K. C. Lim, R. Silasi-Mansat, M. K. Uddin, N. Miura, L. Xia, A. M. Simon, J. D. Engel, H. Chen, F. Lupu, R. S. Srinivasan, “Multiple mouse models of primary lymphedema exhibit distinct defects in lymphovenous valve development,” Dev. Biol. 409, 218–233 (2016).

[37] [37] F. Tatin, A. Taddei, A. Weston, E. Fuchs, D. Devenport, F. Tissir, T. Makinen, “Planar cell polarity protein Celsr1 regulates endothelial adherens junctions and directed cell rearrangements during valve morphogenesis,” Dev. Cell. 26, 31–44 (2013).

[38] [38] M. L. Gonzalez-Garay, M. B. Aldrich, J. C. Rasmussen, R. Guilliod, P. E. Lapinski, P. D. King, E. M. Sevick-Muraca, “A novel mutation in CELSR1 is associated with hereditary lymphedema,” Vasc. Cell 8, 1 (2016).

[39] [39] K. E. Adams, J. C. Rasmussen, C. Darne, I-C. Tan, M. B. Aldrich, M. V. Marshall, C. E. Fife, E. A. Maus, L. A. Smith, R. Guilliod, S. Hoy, E. M. Sevick-Muraca, “Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema,” Biomed. Opt. Express. 1, 114–125 (2010).

[40] [40] T. Yamamoto, M. Narushima, K. Doi, A. Oshima, F. Ogata, M. Mihara, I. Koshima, G. S. Mundinger, “Characteristic indocyanine green lymphography findings in lower extremity lymphedema: The generation of a novel lymphedema severity staging system using dermal backflow patterns,” Plast. Reconstr. Surg. 127, 1979–1986 (2011).

[41] [41] T. Yamamoto, H. Yoshimatsu, M. Narushima, N. Yamamoto, A. Hayashi, I. Koshima, “Indocyanine green lymphography findings in primary leg lymphedema,” Eur. J. Vasc. Endovasc. Surg. 49, 95–102 (2015).

[42] [42] T. Yamamoto, M. Narushima, H. Yoshimatsu, N. Yamamoto, A. Oka, Y. Seki, T. Todokoro, T. Iida, I. Koshima, “Indocyanine green velocity: Lymph transportation capacity deterioration with progression of lymphedema,” Ann. Plast. Surg. 71, 591–594 (2013).

[43] [43] Y. Wang, G. Oliver, “Current views on the function of the lymphatic vasculature in health and disease,” Genes. Dev. 24, 2115–2126 (2010).

[44] [44] H. Brorson, K. Ohlin, G. Olsson, M. K. Karlsson, “Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue,” Lymphat. Res. Bio. 7, 3–10 (2009).

[45] [45] A. Szuba, R. Achula, S. Rockson, “Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression,” Cancer 95, 2260–2367 (2002).

[46] [46] S. C. Muluk, A. T. Hirsch, E. C. Taffe, “Pneumatic compression device treatment of lower extremity lymphedema elicits improved limb volume and patient-reported outcomes,” Eur. J. Vasc. Endovasc. Surg. 46, 480–487 (2013).

[47] [47] S. N. Blumberg, T. Berland, C. Rockman, F. Mussa, A. Brooks, N. Cayne, T. Maldonado, “Pneumatic compression improves quality of life in patients with lower extremity lymphedema,” Ann. Vasc. Surg. (2015), doi: 10.1016/j.avsg.2015.07.004.

[48] [48] A. T. Hirsch, P. K. Mandic, Advanced pneumatic compression device treatment of lymphedema improves health outcomes and lowers cost, in the 11th National Lymphedema Network Int. Conf., Washington, D.C., 3–7 September 2014.

[49] [49] Y. Seki, T. Yamamoto, H. Yoshimatsu, A. Hayashi, A. Kurazono, M. Mori, Y. Kato, I. Koshima, “The superior-edge-of-the-knee incision method in lymphaticovenular anastomosis for lower extremity lymphedema,” Plast. Reconstr. Surg. 136, 665e–675e (2015).

[50] [50] W. L. Olszewski, P. J. Ambujam, M. Zaleska, M. Cakala, “Where do lymph and tissue fluid accumulate in lymphedema of the lower limbs caused by obliteration of lymphatic collectors , ” Lymphology 42, 105–111 (2009).